Major CRISPR patent decision won’t end tangled dispute
Heidi Ledford
Nature, 2022, vol. 603, issue 7901, 373-374
Abstract:
Fights over who invented the gene-editing technology are becoming more complex, and could carry on for years.
Keywords: Biotechnology; Biological techniques; Intellectual-property rights; CRISPR-Cas9 genome editing (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/d41586-022-00629-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:603:y:2022:i:7901:d:10.1038_d41586-022-00629-y
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/d41586-022-00629-y
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().